drugset / Trial / NCT00318630
The Effect Of AVANDIA On The Late Asthmatic Response
RandomizedCrossoverTreatment
Summary
This study is to investigate the effects of AVANDIA on the asthmatic response.
Timeline
- Start
- 2005-07-22
- Primary completion
- 2006-06-30
- Completion
- 2006-06-30
Outcome
Met primary endpoint
paper The late asthmatic reaction (LAR) change from post saline FEV(1) from 4-10 hrs post allergen on day 28 was statistically significant PMID 19944580 ↗
paper Treatment with a PPARgamma agonist (rosiglitazone) was associated with a modest (15%) reduction in the late asthmatic reaction in the allergen challenge model of asthma. PMID 19944580 ↗
Publications
- Background This study has not been published in the scientific literature.
- Richards DB, Bareille P, Lindo EL, Quinn D, Farrow SN. Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: a randomised controlled trial. Respir Med. 2010 May;104(5):668-74. doi: 10.1016/j.rmed.2009.11.006. Epub 2009 Nov 26.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosiglitazone | Small molecule | 4 mg | Oral |